Symptomtext
Soreness of arm; Stiff muscles in movement of arm; Headache; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EAU), via an unspecified route of administration in the left arm on 30Mar2021 at 10:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer, compromised immune system due to chemotherapy, high blood pressure (HBP), irregular heart rate, chondromalacia of both legs, chronic depression and bipolar. The patient previously received morphine and experienced a drug allergy. Prior to the vaccination, the patient had undergone a COVID-19 test twice, on an unspecified date in the year 2020 and another test was on 01Sep2020; she tested negative both the times. The patient did not receive any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 17:30, the patient experienced soreness in arm, very stiff muscles in movement of arm. On the same day, the patient had brief headache that did not last. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On an unknown date in Mar2021, after the vaccination, the patient underwent a COVID-19 test (nasal swab), and tested negative. No therapeutic measures were taken for any of the reported events. The clinical outcome of the events soreness in arm, stiff muscle in movement of arm were resolving at the time of this report. The clinical outcome of the event headache was resolved on an unspecified date in Mar2021. No follow-up attempts are needed. No further information is expected.